Skip to main content
OpenTrials
Completed

NCT Number: NCT03238456

Smoking Cessation for Young Adult Pacific Islanders: Motivating Pacifika Against Cigarettes and Tobacco

The current study aimed to test a culturally tailored program designed to help Pacific Islanders (PIs) between the ages of 18 and 30 quit smoking cigarettes by using a randomized controlled trial design with one intervention group and one control group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Claremont Graduate University, Claremont, California, United States

Loading trial locations.

About this study

This randomized control trial (RCT) consisted of a baseline assessment (Wave 0) and three follow-up assessments (Waves 1-3). Follow-up assessments were conducted at 2 months, 5 months, and 8 months after the baseline assessment. The objective of the study was to test a culturally-tailored online program designed to help PI young adults quit smoking cigarettes. The online program contained (1) personalized, automated text messages, (2) interactive, online educational modules, and (3) an online forum.

Hypotheses for this study include:

  • Participants in the intervention program tailored to PIs would have significantly higher rates of abstinence, lower rates of relapse, and lower smoking frequency and intensity at each follow-up time point than those in the standard intervention program.
  • Participants with impaired affective decision capacity (low scores on Iowa Gambling Task (IGT)) would benefit more from the tailored intervention program than participants with normal affective decision capacity (high IGT scores).
  • Effects from the tailored intervention program would be more pronounced among participants with particular dispositional phenotypes (depression, hostility, impulsivity) and baseline severity of tobacco addiction (nicotine dependence).
  • High-intensity users of the tailored intervention program would be more successful than low intensity users in reducing the frequency and intensity of cigarettes smoked.
  • The tailored intervention program would have greater success at engaging and retaining participants than the standard intervention program.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-identified as Native Hawaiian or Pacific Islander
  • Between the ages 18 and 30
  • Lived in Southern California
  • Would be living in Southern California for the next year
  • Owned a cell phone with a text messaging plan
  • Had access to a computer with internet for at least 2 hours per week
  • Smoked daily or most days of the week (>3 days)
  • Smoked at least 100 cigarettes in lifetime

Exclusion criteria

  • Was currently using another smoking cessation method

Treatment and study plan

Motivating Pacifika Against Cigarettes and Tobacco

Behavioral

Participants received one encouraging text message per day prior to their quit date. During the intervention, they received daily text messages with decreasing frequency per week. Participants were also able to craft personal text messages. On-demand text messages were optional and could be requested by texting key words to the program hotline.

The online MPACT program allowed participants to access eight educational modules and a forum where they could communicate with other participants. The modules focused on different aspects of quitting smoking, such as how to deal with withdrawal symptoms, triggers of tobacco use, and stress. Participants were limited to one module per day in order to increase the duration of exposure to the program. Upon completion, participants no longer received text messages but they were still able to access the educational modules, forum, and on-demand text messages.

Other names: MPACT

Primary outcomes

  1. Number of cigarettes smoked in last 30 days

    Time frame: 8 months

    How many cigarettes has the participant smoked in the last 30 days?

  2. Cigarette smoked in past 7 days

    Time frame: 8 months

    Has the participant smoked a cigarette in the past 7 days?

  3. Cigarette smoked in past 24 hours

    Time frame: 8 months

    Has the participant smoked a cigarette in the past 24 hours?

  4. Expired carbon monoxide (CO)

    Time frame: 8 months

    Biomarker validation (expired CO) of self-reported tobacco use

Secondary outcomes

  1. Number of cigarettes smoked in last 30 days

    Time frame: 2 months

    How many cigarettes has the participant smoked in the last 30 days?

  2. Number of cigarettes smoked in last 30 days

    Time frame: 5 months

    How many cigarettes has the participant smoked in the last 30 days?

  3. Cigarette smoked in past 7 days

    Time frame: 2 months

    Has the participant smoked a cigarette in the past 7 days?

  4. Cigarette smoked in past 7 days

    Time frame: 5 months

    Has the participant smoked a cigarette in the past 7 days?

  5. Cigarette smoked in past 24 hours

    Time frame: 2 months

    Has the participant smoked a cigarette in the past 24 hours?

  6. Cigarette smoked in past 24 hours

    Time frame: 5 months

    Has the participant smoked a cigarette in the past 24 hours?

  7. Expired carbon monoxide (CO)

    Time frame: 2 months

    Biomarker validation (expired CO) of self-reported tobacco use

  8. Expired carbon monoxide (CO)

    Time frame: 5 months

    Biomarker validation (expired CO) of self-reported tobacco use

Sponsors and collaborators

Lead sponsor

Claremont Graduate University

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Weaving an Islander Network for Cancer Awareness, Research and Training (WINCART): Technology & Smoking Cessation for Late Adolescent/Young Adult Pacific Islanders

Acronym: MPACT

Important dates

Study start
2013
Primary completion
2014
Study completion
2015
First posted
Aug 3, 2017
Registry last updated
Aug 4, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.